止咳藥市場規模 - 依藥物類型（抗組織胺、抗生素、支氣管擴張劑、減充血劑、祛痰藥）、劑型（口服糖漿、片劑/丸劑、滴鼻劑、含片）、年齡層、配銷通路與預測，2024年至2032年

在政府嚴格核准以確保安全標準的推動下，咳嗽藥物市場規模預計從 2024 年到 2032 年複合年成長率將達到 5.6%。由於當局正在完善安全協議並審查新配方，因此監管機構正在評估其有效性和潛在副作用。

研究人員和製造商正在探索符合不斷變化的監管要求的創新成分和配方。高度重視提高療效，同時最大限度地降低風險，以確保咳嗽藥物對公眾使用仍然安全可靠，這將推動該行業的成長。例如，2023 年 12 月，印度藥品監管總局 (DCGI) 發起了一項全國性行動，以確保止咳糖漿生產的全球品質標準。這項工作正在提高全國咳嗽藥物的安全性和有效性標準。

整個市場分為藥物類型、劑型、年齡層、配銷通路和地區。

就藥物類型而言，抗組織胺領域的咳嗽藥市場預計從2024 年至2032 年將錄得顯著的複合年成長率。緩解過敏反應。人們也研究了它們在治療各種過敏性疾病和症狀方面的潛力。不斷努力為受過敏影響的個人提供更有針對性和更有效的緩解，同時確保提高生活品質和更好地管理過敏反應，將有利於該細分市場的成長。

按配銷通路，線上藥局領域的止咳藥產業預計將在 2024 年至 2032 年期間成長，因為它們能夠透過提供便利的數位平台購買和交付醫療保健產品，從而改變藥物取得管道。線上管道正在擴大服務範圍，提供各種處方藥和非處方藥以及健康相關產品。他們還整合遠距醫療服務，以改善用戶介面並增強整體客戶體驗。

從地區來看，在廣告和促銷活動的增加以及生活方式的改變的推動下，亞太地區止咳藥市場規模預計將在 2024 年至 2032 年間呈現強勁成長。隨著該地區城市化和生活方式的不斷發展，人們不斷努力為城市居民量身定做行銷策略。這種適應包括更廣泛地利用數位平台，並製作有針對性的資訊，以引起城市消費者的共鳴，尋求便捷有效的解決方案來管理該地區的呼吸健康。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

• 產業生態系統分析
• 產業影響力
  • 成長動力
    • 呼吸道疾病盛行率增加
    • 對非處方 (OTC) 產品的認知程度和需求提高
    • 老年人口激增
  • 產業陷阱與挑戰
    • 與止咳藥物相關的副作用
• 成長潛力分析
• 監管環境
• 管道分析
• 波特的分析
• PESTEL分析
• 未來市場趨勢

第 4 章：競爭格局

• 介紹
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 戰略儀表板

第 5 章：市場估計與預測：按藥物類型，2021 - 2032 年

• 主要趨勢
• 抗組織胺藥
• 抗生素
• 支氣管擴張劑
• 減充血劑
• 祛痰藥

第 6 章：市場估計與預測：按劑型，2021 - 2032

• 主要趨勢
• 口服糖漿
• 片劑/丸劑
• 滴鼻液
• 含片

第 7 章：市場估計與預測：按年齡分類，2021 - 2032

• 主要趨勢
• 成人
• 兒科

第 8 章：市場估計與預測：按配銷通路分類，2021 - 2032 年

• 主要趨勢
• 零售藥房
• 醫院藥房
• 網路藥房
• 其他分銷管道

第 9 章：市場估計與預測：按地區，2021 - 2032

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
  • 歐洲其他地區
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
  • 亞太地區其他地區
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地區
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 中東和非洲其他地區

第 10 章：公司簡介

• AstraZeneca plc
• Bayer AG
• GSK plc
• Johnson & Johnson
• Novartis AG
• Pfizer Inc.
• Prestige Consumer Healthcare
• Procter & Gamble
• Reckitt Benckiser Group plc
• Sun Pharmaceutical Industries Ltd

Cough Remedies Market size is projected to record 5.6% CAGR from 2024 to 2032, driven by stringent government approvals to ensure safety standards. Regulatory agencies are assessing their effectiveness and potential side effects due to rising scrutiny as authorities are refining safety protocols and reviewing new formulations.

Researchers and manufacturers are exploring innovative ingredients and formulations that comply with evolving regulatory requirements. The strong focus on enhancing efficacy while minimizing risks for ensuring that cough remedies remain safe and reliable for public use will drive the industry growth. For instance, in December 2023, the Drugs Controller General of India (DCGI) initiated a nationwide drive for ensuring global quality standards in cough syrup manufacturing. This effort is enhancing safety and efficacy standards for cough remedies across the country.

The overall market is segregated into medication type, dosage form, age group, distribution channel, and region.

In terms of medication type, the cough remedies market from the antihistamines segment is expected to record significant CAGR from 2024 to 2032. Antihistamines are widely utilized to alleviate allergic reactions by blocking histamine receptors in the body. They are also researched for their potential in treating various allergic conditions and symptoms. Rising efforts for providing more targeted and efficient relief for individuals affected by allergies while ensuring improved quality of life and better management of allergic reactions will favor the segment growth.

By distribution channel, the cough remedies industry from the online pharmacy segment is projected to rise from 2024 to 2032, driven by their ability of transforming access to medications by providing convenient digital platforms for purchasing and delivering healthcare products. Online channels are expanding their services to offer a wide range of prescription and over-the-counter medications, as well as health-related products. They are also integrating telemedicine services to improve user interface as well as enhance the overall customer experience.

Regionally, the Asia Pacific cough remedies market size is projected to exhibit robust growth between 2024 and 2032, fueled by the rise in advertising and promotional campaigns, along with changing lifestyles. As urbanization and lifestyles are evolving in the region, there are ongoing efforts to tailor marketing strategies to urban dwellers. This adaptation involves utilizing digital platforms more extensively and crafting targeted messages to resonate with urban consumers seeking convenient and effective solutions for managing respiratory health in the region.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increase in prevalence of respiratory diseases
    • 3.2.1.2 Rise in awareness levels and demand for over-the-counter (OTC) products
    • 3.2.1.3 Surging geriatric population
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Side effects associated with cough medications
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Pipeline analysis
• 3.6 Porter's analysis
• 3.7 PESTEL analysis
• 3.8 Future market trends

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Medication Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Antihistamines
• 5.3 Antibiotics
• 5.4 Bronchodilators
• 5.5 Decongestants
• 5.6 Expectorants

Chapter 6 Market Estimates and Forecast, By Dosage Form, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Oral syrups
• 6.3 Tablets/Pills
• 6.4 Nasal drop
• 6.5 Lozenges

Chapter 7 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Adult
• 7.3 Pediatric

Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Retail pharmacy
• 8.3 Hospital pharmacy
• 8.4 Online pharmacy
• 8.5 Other distribution channels

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 AstraZeneca plc
• 10.2 Bayer AG
• 10.3 GSK plc
• 10.4 Johnson & Johnson
• 10.5 Novartis AG
• 10.6 Pfizer Inc.
• 10.7 Prestige Consumer Healthcare
• 10.8 Procter & Gamble
• 10.9 Reckitt Benckiser Group plc
• 10.10 Sun Pharmaceutical Industries Ltd